Biostatistics and Epidemiology Symposium 2022 | Stata
2022 Stata
Biostatistics and
Epidemiology
Virtual Symposium
7 April 2022
What is this
symposium
What is this symposium
Join us for the 2022 Stata Biostatistics and Epidemiology Virtual Symposium, where researchers in biostatistics and epidemiology around the world will discuss current research methods and implementation using Stata. The program consists of invited talks by top Stata users, and the virtual platform allows you to experience this one-day event from wherever you are. Seats are limited. Register now to learn and connect with fellow Stata users.
Program at
a glance
Program at a glance
Enjoy insightful and informative presentations by these experienced Stata users in the field. All times CST.
8:50 a.m.
Social time, welcome, and introductions
9:00 a.m.
Simulating clinical trial designs
Abstract:
Increasingly clinical trial designs are becoming more complex and therefore do not have simple formulae for determining the sample size and operating characteristics of the design.
… (Read more)
In the absence of formulae, simulation is the tool of choice, but often trial statisticians are not fully aware of how to do the simulations. Trial simulations in Stata are easily achieved by writing many lines of code, but I introduce a new command, tacts, that attempts to run the simulations within a single line of code. This command will handle many different types of design, such as MAMS, trials with longitudinal outcomes, sample size re-estimation, multiple-outcome trials with multiplicity correction, and adaptive randomization. The command will also be able to gather the output of the simulations and produce a summary table of the results. To handle the complexity of all of these trials requires a complex syntax that is very flexible.
(Read less)
Adrian Mander, Cardiff University
9:30 a.m.
merlin in Stata: Joint models, multistate models, and more
Abstract: The challenges in statistics and data science are growing as access to a multitude of data types continue to increase, as well as the sheer quantity of data.
… (Read more)
Analysts are now presented with multivariate data, sometimes measured repeatedly, and often requiring the ability to model nonlinear relationships and hierarchical structures. In this talk, I will give an overview of the merlin command, which attempts to provide an extremely general framework for data analysis. From simple things, like fitting a linear regression model or a Weibull survival model to a three-level logistic mixed-effects model, or a multivariate joint model of multiple longitudinal outcomes (of different types) and a recurrent event and survival with nonlinear effects…merlin can fit them all. I’ll take a single dataset and attempt to show you the full range of capabilities of merlin before diving into some new tricks in the field of multistate survival modelling.
(Read less)
Michael Crowther, Karolinska Institutet
10:15 a.m.
Survival by first-line treatment type and timing of progression among follicular lymphoma patients
Abstract: In follicular lymphoma (FL), progression of disease within 24 months has emerged as a popular prognostic marker for overall survival (OS).
… (Read more)
While it has considerable clinical relevance, there are also inherent limitations in relation to the fixed time point of 24 months and potential variation by treatment type and choice of comparison group. In this talk, I will highlight some of the methodical limitations and present the first results from a large population-based cohort of FL patients. National register-based information has been combined with detailed medical record data to create a unique cohort with detailed treatment and follow-up information. We allow progression to be time-varying and estimate relative rates, as well as OS, by first-line treatment and timing of progression using an illness-death modeling approach. Stata packages merlin and multistate were applied, and example code will be presented. Our findings show that progression is associated with worse survival beyond the 24-month time point, illustrating the need for individualized management by timing of progression for optimal care of patients with FL.
(Read less)
Caroline Weibull, Karolinska Institutet
Wästerlid T, Wahling BE, Andersson PO, Ekberg S, Lockmer S, Enblad G, Crowther MJ, Kimby E, Smedby KE
10:45 a.m
Multivariate semiparametric analysis of event-time interval-censored data
Abstract: forthcoming
Danyu Lin and Donglin Zeng, University of North Carolina
11:45 a.m.
Multivariate interval-censored Cox model in Stata
Abstract: In this presentation, we describe the early results of Stata’s phase II Small Business Innovative Research (SBIR) grant, “Software for Cox Regression Analysis of Interval-Censored Data”.
… (Read more)
We present a new prototype command, mvintcox, for fitting multivariate interval-censored event-time models in Stata and demonstrate its use with several real-world applications.
(Read less)
Yulia Marchenko and Xiao Yang, StataCorp
12:15 p.m.
Break + Lunch
1:15 p.m.
Network meta-analysis using Stata: Principles and applications
Abstract: There is an urgent need to translate experimental interventions from research environments into clinical practice, which requires the comparison of effectiveness and safety among several interventions used to treat the same condition and select the most appropriate (comparative effectiveness research – CER).
… (Read more)
Classically, it has been used for conventional pairwise meta-analysis to compare the effects between treatments based on head-to-head comparisons; however, data from direct comparisons are relatively limited, hampering the knowledge translation and clinical decision-making. An alternative analytical approach called network meta-analysis (NMA) was developed to include in the meta-analysis not only direct comparisons but also indirect comparisons based on logical inference (and assumptions) from the network model. This approach is being used rapidly because it maximizes the way we use evidence to clinical decision making. In this lecture, we will introduce NMA definitions, relevant statistical concepts, and the frequentist NMA analytics process to be implemented using Stata with a practical example from the fibromyalgia literature.
(Read less)
Felipe Fregni and Kevin Pacheco-Barrios, Harvard University
1:45 p.m.
Title forthcoming
Joni Ricks-Oddie, UCI Center for Statistical Consulting and ICTS
2:30 p.m.
Methodological issues and strategies for using and measuring race in regression analyses
Abstract: There is a vast array of literature on racial and ethnic disparities in health and broad consensus in the public health field that race is a social construct.
… (Read more)
However, most biostatistical and epidemiological researchers are not cognizant of the ways their understandings of race and ethnicity seep into their research designs and statistical analyses. It is important to consider how the social construction of race and ethnicity influences the ways in which biostatisticians and other researchers measure racial and ethnic phenomena, including racial and ethnic disparities. This talk includes a discussion of different coding strategies and the promise of nested models for critical studies of race and racism using regression analysis.
(Read less)
Melody Goodman, New York University
We are pleased to announce that all proceeds from registrations for the 2022 Stata Biostatistics and Epidemiology Virtual Symposium will be donated to Save the Children.
Location: Virtual
Registration fee: $45